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Summary: Prolactin exists in biological fluids in several molecular forms. This raises two questions:
(1) whether the assay of prolactin by immunotechniques is valid and reliable and
(2) whether the different forms have different physiological roles, which might be exploited to improve
diagnostic accuracy and data interpretation by the use of appropriate methods.
To investigate these questions, prolactin from human amniotic fluid was separated, by concanavalin A-
Sepharose affinity chromatography, into bound, retarded and unbound fractions (bound prolactin fraction,
retarded prolactin fraction, unbound prolactin fraction), which were characterized by electrophoresis, im-
munoblotting and glycan detection blot. Virtually no contamination was found in the bound prolactin
fraction, and the unbound prolactin fraction and retarded prolactin fraction were 74—83% pure according
to densitometry of the electrophoretic and immunoblot patterns. High variability was found among the
individual patterns. Glycan detection in the blotted fractions revealed that the bound prolactin fraction bands
corresponding to Mr 25000—29000 were weakly glycolysated, whereas the bands of 60000 — 64000 were
significantly glycan-positive. Immunoreactive bands of unbound prolactin fraction and retarded prolactin
fraction also stained positively for glycans. Using two commercial prolactin kits, the bound prolactin fraction
forms were virtually undetectable. To demonstrate that the prolactin forms may depend on the hypothalamic
state, two behaviourly different breeds of cattle were used as an animal model for studying hypothalamic
activities, The number of immunoreactive bands, representing the prolactin forms, and the change of the
forms in response to thyroliberin differed strikingly among the groups.
The bioactivity of the forms was examined in bovine granulosa, oviductal, endometrial and spleen cells, and
in murine splenocytes, the latter being activated by concanavalin A or allogeneically to create in vitro
conditions that may have relevance for situations in vivo. The rate of incorporation of [3H]thymidine in
murine splenocytes was dose-dependently enhanced only by bound prolactin fraction. The increase was
abolished by purified anti-prolactin antiserum. However, the standard prolactin from the kits inhibited the
proliferation even in low dose (1.25 g/l) and the inhibition was abolished in part by bound prolactin fraction.
Thymidine incorporation into the bovine cells was significantly increased by low concentrations (2 g/l) of
unbound prolactin fraction and retarded prolactin fraction. Oviduct epithelial cells and splenocytes were
stimulated by unbound prolactin fraction but not by retarded prolactin fraction in a dose of 16 §/\. Thymidine
incorporation into granulosa cells was inhibited by retarded prolactin fraction (16 g/l) but not by unbound
prolactin fraction.
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Thus, various prolactin forms can have not only different but also opposite effects in a cell system that models
a given physiological situation in vivo, suggesting that both immuno- and bioassays need to be carefully
defined, if measurements of prolactins are to be valid and reliable.
Introduction
The prolactin concentration in serum is a commonly
used diagnostic quantity for human reproductive dis-
orders. However, the existence of prolactin in several
molecular forms raises questions regarding both the
accuracy of prolactin assays and the diagnostic sig-
nificance of the determined values. When prolactin is
assayed with immunotechniques, the accuracy de-
pends on the antigenic similarity between the forms.
Prerequisite for reliable diagnosis is a knowledge of
the physiological significance of the molecular form
detected. Recently, growing evidence has demon-
strated that .prolactin patterns are altered according
to the physiological situation (1) and that the prolac-
tin forms differ in their bioactivities (2 — 5). Without
further elucidation of the dissimilarities in the prop-
erties and functions of prolactin forms, the mechanism
by which prolactin interferes with particular stages of
the reproductive process may remain controversial. A
better understanding of the biological significance of
the molecular forms is needed to clarify their diag-
nostic value. We therefore investigated the molecular
heterogeneity, the degree of glycosylation and the
immuno- and bioactivities of prolactin fractions, sep-
arated by concanavalin A-Sepharose from human am-
niotic fluid, and studied the relation between circu-
lating prolactin forms and hypothalamic activity.
Materials and Methods
Animals
Mice were obtained from an outbreeding colony maintained in
the Department of Population Biology under clean conditions
and were provided with water and commercial laboratory food
(Altromin) ad libitum. The reproductive organs were from
heifers (Friesian cattle) slaughtered in the local slaughter house.
In experiments in which the alteration of the circulating pro-
lactin pattern was challenged by hypothalamic peptides, four
young bulls aged 12 months of two breeds of cattle (Galloway
and Friesian) and two control animals were used in each case.
The animals were kept in the experimental station of our
institute and provided with food with a calorific value sufficient
' for maintenance.
Murine splenocytes
The spleens were minced and passed through a nylon mesh
(pore size 40-45 μηι) by gentle grinding and flushing with
complete RPMI containing 0.001 mol/1 ethylenediaminetetra-
acetic acid (EDTA). The ingredients of the complete RPMI
medium were: RPMI 1640 with L-glutamine, Hepes (0.02 mol/1)
pH 7.2, streptomycin (160 mg/1), fungizone (Squibb, 4mg/l),
nutridoma (Boehringer, 10 g/1), -mercaptoethanol (50 μπιοΐ/ΐ).
Materials were from Serva when not otherwise stated.
Erythrocytes were lysed by addition of 10 volumes lysis solution
(7g/l NH4C1, 1.5 g/1 NaCl, 0.02 mol/1 Hepes, 0.0012 mol/1
Na2CO3, 0.001 mol/1 neutralized EDTA), and gentle shaking
for 2 min. Following centrifugation (900 g, 4 min) the cells were
resuspended in distilled water at room temperature to remove
residues of the lysis solution and water soluble precipitates.
After 15s, dissolved NaCl was added to a final concentration
of 8.5 g/1. The cells were centrifuged (600 g, 5 mm) and re-
suspended in complete RPMI to 1010/1- Aliquots were taken
and plated (1,5 · 105 cells per well plate, culture volume 200 μΐ).
Viability was > 95% (assessed by trypan blue exclusion). The
cells were cultured at 37 °C in a humidified air atmosphere for
96 h without (control) and with additives specified under Re-
sults. The culture was terminated on day 4 by addition of
EDTA (final concentration 0.01 mol/1) and incubation over-
night. The cells were resuspended and an aliquot was taken for
cell counting according to the Coulter principle in a cojiphic-
tometric cell counter (Sch rfe).
Splenocyte activation
The murine cells were stimulated either semiallogeneically or
by concanavalin A. In semiallogeneic stimulation, 1 · 10s cells
from spleens of the mother and their offspring (3 days old)
were co-cultured (96 well culture plates). In concanavalin A
stimulation 5 mg of concanavalin A per litre of medium were
used. After incubation for 24 h, the supernatant was aspirated
and replaced by medium containing prolactin in concentrations
specified under Results (fig. 5).
Bovine cells
The bioactivity of prolactin forms was studied in bovine cell
systems prepared from the reproductive organs and spleen of
heifers (15). Materials in the cell preparation were from Serva
when not otherwise stated.
Granulosa: Ovarian follicles (diameter of 2—4 mm) were aspi-
rated with a syringe containing Dulbecco's phosphate buffered
saline with 0.01 mol/1 EDTA. The cell aggregates were dispersed
by pipetting, and the cells were centrifuged and resuspended in
serum-free RPMI 1640-medium containing 0.01 mol/1 of EDTA
and 20 mmol/1 Hepes (pH 7.3).
Oviductal epithelial cells: Excess connective tissue was trimmed
from the oviducts, which were then washed in TCM 199 me-
dium supplemented with fetal calf serum, (volume fraction 0.1)
and flushed from the ampullary end towards the utero tubal
junction with 10 ml TCM 199-FCS medium. The flow-through
was collected and centrifuged (500 g, 10 min). The cells were
resuspended in serum-free RPMI 1640-medium.
Stromal cells: Endometriurn samples were minced into Hank's
balanced salt solution without divalent cations. After enzymatic
removal of luminal epithelium the tissue was digested with
trypsin and collagenase (16). The suspended cells were frac-
tionated by gravity settling.
The stroma cells in the supernatant were centrifuged (1000g,
5 min), washed with Hank's balanced salt solution and re-
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suspended in RPMI1640 medium supplemented with fetal calf
serum (volume fraction 0.1). The cells were plated (50 cm2
culture flasks) and grown as monolayers (5 days) changing the
medium after 3 days. On the fifth day the cells were rinsed with
Hank's balanced salt solution, trypsinized and subcultured in
serum-free RPMI 1640 medium. The resulting stromal cell
preparation contained more than 95% stromal cells, according
to a vimentin assay (.14).
Bovine splenocytes:Sp\eens were stored in sodium phosphate
(0.01 mol/I)-buffered saline (pH 7.4) on ice. The spleen was
minced on a plastic screen, pore-size 45 μιη. The erythrocytes
were lysed (7.8 g/1 of NH4C1), and the remaining cells were
washed in phosphate buffered saline (500 #, 5 min) and re-
suspended in RPMI 1640 medium supplemented with fetal calf
serum, volume fraction 0.05.
Cell culture: The cells were counted by a haemocytometer or
conductometrically (Casy 1-cell analyser system, Sch rfe). The
viability was assessed by trypan blue exclusion (all preparations
contained > 95% vital cells). The cells were grown in 96 well
culture plates (Greiner) at a density of 2 χ 10s cells per well
using a volume of 50 μΐ RPMI 1640 medium and 50 μΐ RPMI
1640 medium supplemented with additives in the final concen-
trations specified in the figures. Controls contained only me-
dium. Cells were incubated for 48 hours at 37 °C in a humidified
CO2-air mixture (& volume CO2). Finally 250 pmol of
[3H]thymidine (Nuclear Research Institute, Rossendorf-Berlin)
were added per well. After 18 hours the cells were harvested by
a semiautomated harvester (Skatron) on glass fibre disks
(Whatman). The radioactivity was determined by liquid scin-
tillation counting.
Modelling of al teration in c i rcu la t ing prolactin
forms
Two breeds of cattle were used (Friesian and Galloway). The
animals were trapped and bled via the v. jugularis (blood sample
at 0 min). Thyroliberin (4 or 8 μg/kg body weight) dissolved in
physiological saline (2 ml) was infused via the v. jugularis. After
15 and 60 minutes the bleeding was repeated. Thyroliberin was
purchased from Sigma.
Assays
Prolactin was determined with commercially available ELISA-
kits (Milenia and Medgenix) or by densitometric quantitation
of the electrophoretic and immunoblot bands with DESAGA
equipment, calibrating the arbitrary units with commercial pro-
lactin (Fluka) by electrophoretic and immunoblot analysis (7).
The densitometric quantitation of the glycan moiety of the
prolactins (detected with the glycan detection kit from Boeh-
ringer) was standardized with transferrin.
Protein determination
An aliquot (20 μΐ) from either the sample to be determined or
the standard solution containing 10,20,40, or 80 mg/1 of bovine
serum albumin (Serva) or transferrin (Sigma) was added to 100
μΐ Coomassie solution (50 mg of Coomassie G 250 were dis-
solved in 50ml methanol and diluted with 300 ml distilled
water, after addition of 50 ml H3PO4 (850 g/1) with vigorous
shaking the solution was adjusted to 500 ml with distilled
water). Within 10 min, the absorbance at 492 nm was recorded
using a microplate reader (Behring).
Antisera
Rabbit anti-human prolactin antiserum was purchased (DAK.O)
or obtained by a standard rabbit immunization protocol util-
izing purified human prolactin forms from amniotic fluid. In
the proliferation studies and the immunoblot the antisera gave
comparable results. Anti-prolactin antiserum and preimmune
serum were purified by protein A affinity chromatography using
the standard protocol of the manufacturer (Pharmacia).
Prolactin preparat ion
Human amniotic fluid was collected from full-term deliveries
and stored at -20 °C. After thawing, centrifugation (110 000 g,
20 min, 4 °C) and filtration to remove the lipids, glycinc was
added (0.25 mol/1), the pH was adjusted to 7.6 with ammonia
and the solution was dialysed against CH3CN (final concentra-
tion 0.61 -0.63 1/1 dialysate) overnight al 4 °C. The precipitates
were removed by centrifugation (6000 g, 10 min, 4°C), urea
was added (2 mol/1) and the organic phase was evaporated in
vacuo. Following the addition of NH4HCO3 (0.08 mol/1, pH 8),
anion exchange chromatography was performed (1 volume of
DEAE A25 (Pharmacia) equilibrated in 100 mmol/1 NH4HCO3,
pH 8, per 8 volumes of evaporated fluid), the flow-through was
collected, glycine was added (0.1 mol/1) and portions of 1 ml
were lyophilized. The product was fractionated by concanavalin
A Sepharose 4B (Pharmacia) affinity chromatography using
2ml gel per column. The lyophilized product (total protein
80—100 μg) was dissolved in 1 ml of distilled water and dialyzed
against 50 volumes binding buffer (0.1 mol/1 Tris-HCl, pH 7.5,
0.3 mol/1 NaCl, 0.005 mol/1 MgCl2) overnight at 4 °C. After
rinsing of the gel with binding buffer (8 ml), the column was
loaded, then washed with binding buffer at a flow rate of 1.8
ml/h until the absorbance at 280 nm (recorded by a Uvicord
and Alphaplot (LKB)), was nearly zero. The retained material
was eluted with 0.2 mol/1 methyl-a-/)-glucoside in binding buf-
fer.
Electrophoresis and western blot
Samples were electrophoresed under non-reducing conditions
using polyacrylamide gels in the presence of sodium dodecyl
sulphate and stained as described (7). In the analysis of the
cicrulating prolactin forms, the serum (1 volume) was diluted
with 15 volumes of 0.125 mol/1 Tris-HCl, pH 6.8, supplemented
with 1 g/1 sodium dodecyl sulphate.
The blot was performed with nitrocellulose sheets (Schleicher
& Sch li, 0.45 μηι pore size): the gels were placed on 3 filter
papers soaked with cathode buffer (0.04 mol/1 6-aminohexanoic
acid, 200 ml/1 methanol) then covered with the nitrocellulose,
followed by a single filter paper (previously soaked in anode
buffer: 0.015 mol/1 Tris, 200 ml/1 methanol), which was pressed
on top. The next 2 filters were soaked in 0.3 mol/1 Tris, 200
ml/1 methanol. After the electrotransfer (1 mA/cm2, 1 h), the
nitrocellulose was blocked with 0.3 g/l Gelafusal (Serumwerk
Bernburg) in 0.05 mol/1 Tris-HCl, 0.2 mol/1 NaCl, pH 7.4 (Tris
buffered saline) and stained either by the immunotechnique (7)
using rabbit antiprolactin antiserum (DAKO) diluted 1 :200
with Tris buffered saline-0.1 g/1 Gelafusal, and antirabbit per-
oxidase-conjugated biotin-avidin antibody system from Vektor
Laboratories, or with the glycan detection kit (Boehringer). .
Statistical analysis
Differences were compared between the control group mean
and a test group mean in each case. Three experiments were
performed (when not otherwise stated), in which the variants
were run in triplicate. The significance of differences was de-
termined by Student's t-test, using the modification of Cochran-
Cox for unequal variances. This was judged by the F-test in
the analysis of variances. An error probability of P < 0.05 for
the theoretical t-values was used. The results are reported as
M (mean) and SD (standard deviation) or SEM (standard error
of the mean).
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Results
Different amniotic fluids contain different
patterns of prolactins
The prolactin patterns of 6 individual amniotic fluids
were examined by electrophoresis (fig. 1). All electro-
pherograms indicated a band of Mr 29 000. In 5 phero-
grams, bands of Mr 28000, 60000 and 64000 were
observed. Four pherograms displayed bands of Mr
24000, 39000-41000, while 3 pherograms also
showed bands of Μτ 14500, 20000, 25000, 27000,
87000, 117000, and 125000. A band of Afr 140000
































All these bands were immunoreactive, as illustrated
by the analysis of amniotic fluid number 1 (fig. 3).
However, as this fluid did not reveal the Mt 20000,
Mr 39000-41000 and high-molecular mass forms,
these immunoreactive bands ar9 not shown. Figure 1
demonstrates further, that the processing procedure
and the electrophoretic analysis provide highly repro-
ducible results. Only in the region of Mr 125000-
140000 and in the double band of MT 28000 did the
repeated experiment give an ambigous result.
Different forms of prolactin separated from
amniotic fluid by concanavalin A-Sepharose
chromatography are not adequately detected
by the usual immunoassays
Concanavalin A-Sepharose affinity chromatography
was employed to separate the prolactins of amniotic
fluid in order to examine whether defined forms differ
in immuno- and bioassays. Figure 2 depicts the profile
of an amniotic fluid product separated by chroma-
tography, with absorbance recorded at 280 nm. The
profile shows two peaks of which the first is shoul-
dered. The first peak emerges by washing the column
with binding buffer, the second during elution with
methyl-α-Z)-glycoside. After loading 80 μg of total
protein, the first peak yielded 46.4 μg and the second
yielded 5.8 μg protein, of which only 2—3 μg and
3 —5 ng, respectively, were identified as prolactin by
commercial immunoassay kits. This type of chromat-
ogram profile was highly reproducible for any given
amniotic fluid. However, in 2 of the 6 amniotic fluids,
separation of the first shouldered peak was almost
complete (data not shown).
Fig. 1. Silver stained electropherograms of prolactin patterns from amniotic fluid, and of prolactins bound to Concanavalin A-
Sepharose.
The volume of the amniotic fluid was 200 ml in each case. Half of this was used for repeating the preparation procedure
and electrophoretic analysis of the product under non-reducing conditions (12.5% SDS-PAGE). The gel was loaded with
5 μg of total protein in each case, except lane 3 (1 μg). Lanes 1 and 2 depict the bands of the repeated experiment using
the preparation 5. Lane 3 shows the band pattern from prolactins bound to Concanavatin A-Sepharose. Lane 4 contains
molecular mass markers.
Comparison of 1 with 2 indicates that the repeated preparation and electrophoretic procedure provide almost identical
results (the SEM of the estimated relative molecular masses in triplicate experiments were MT 500—1000). Bands probably
corresponding to prolactin forms are listed below in order of their relative molecular masses, for each of the 6 investigated
samples of amniotic fluid:





















































All Mr-values shown on the figure and in the table have been multiplied by 10~3. The band corresponding to Mr 140 χ ΙΟ3
in preparation 6 was absent in the repeated analysis; d indicates the presence of a double band, which was not further
defined.
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Concanavalin A-Sepharose chromatography
provides highly purified glycosylated pro-
lactins
The electrophoretic patterns of the material from both
peaks obtained by concanavalin A-Sepharose affinity
chromatography were developed by Coomassie and
silver staining (fig. 3a and b) to demonstrate not only
the reproducibility but also differences in the stain
intensity. Silver staining involves oxidizable hydroxyl
groups, so that highly glycosylated proteins may be
more intensively stained by the silver stain procedure
than by Coomassie dye binding. Direct glycan detec-
tion revealed significant quantities of glycan in the
MT 60 000 — 64 000 region. Varying amounts of glycan
were observed in the MT 25000-29000 bands, with
an intensity similar to that of the transferrin band
containing 58 μg glycan moiety per mg protein. Es-
pecially the MT 60000 — 64000 prolactins were obvi-
ously more intensively stained by direct glycan detec-
tion and silver staining than by Coomassie dye bind-
ing.
Using equal quantities of total protein, the direct
glycan detection of immunoreactive bands (fig. 3c) on
blotted gels (fig. 3d) was only weakly correlated with
the degree of staining.
The proteins from the second composite peak were
almost complete immunoreactive, whereas the densi-
tometric analysis of both fractions of the first shoul-
dered peak indicated that 74—83% of the stain den-
sity corresponded to prolactin forms (data not
shown). Despite the purification potential of the con-
canavalin A-Sepharpse chromatography for glycosy-
lated forms per se, more than one peak contains
several overlapping forms of similar molecular mass
and degree of glycosylation. That they are only mod-
erately separable (indicated by the distribution of the
molecular masses described in fig. 2) suggests dissim-
ilarities in their glycan structure.
Hypothalamic activity alters the circulating
prolactin pattern
An animal model was used to demonstrate that the
prolactin forms do not vary randomly, but the pattern
may correspond to hypothalamic activity. Two be-
haviourly different breeds of cattle were exposed to
thyroliberin. The behaviour of the two animal groups
was distinguished by the flight-fight syndrome (17)
under bleeding, stress (fig. 4). If the prolactin pattern
is in any way dependent on the physiological situation
and especially on hypothalamic activity induced by
stress, the different circulating prolactin forms are to
be expected in behaviourly different groups after chal-
lange by hypothalamic neurohormones. Figure 4
shows this to be the case. Both behavioural groups
differed in the sensitivity to the bleeding stress and to
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Fig. 2. Concanavalin A affinity chromatogram profile.
Absorbance of the effluent was recorded at 280 nm.
After loading with prolactin-containing solution dia-
lyzed against binding buffer, the column was washed
with binding buffer.
The arrow indicates the start of the elution with methyl-
α-D-glucoside, with the ultraviolet absorbance amplified
10-fold. Pooled fractions 6—20 of peak 1 had a volume
of 5.6 ml and an absorbance at 280 nm of 0.004. Pooled
fractions 26—36 of peak 2 amounted 4ml with an
absorbance at 280 nm of 0.0006.
Preliminary experiments using glycosylated and non-
glycosylated proteins (transferrin and bovine serum al-
bumin) as standards, and comparing the results of the
protein determination (protein dye-binding and ultra-
violet absorbance) showed that 1 g/1 of the almost pure
prolactin obtained in peak 2 has an absorbance at 280
nm of 0.5. Using this result, the pooled fractions con-
tained 46.4 and 5.8 μg respectively. The solution loaded
onto the column contained 80 μg of protein determined
by Coomassie dye binding. Thus, the protein recovery
was 66% for the chosen fractions, but 87% based on
all fractions.
The proteins of peaks 1 and 2 were electrophoresed
under non-reducing conditions; the following bands
were identified as prolactins by immunoblot: in peak 1,
Mr 14500-16000, 20000, 27000, 29000, 117000-
140000; in the shoulder of peak 1 (fractions 12-20),
Mr 14500-16000, 24000-25000, 28000-29000,
60000-64000, 87000, 117000-140000; in peak 2 Mr
27000-29000, 39000-41000, 60000-64000, 87000.
Densitometric quantitation revealed 74—83% of the
proteins in peak 1 were prolactins. The peak 2 forms
were virtually uncontaminated with other proteins.
Commercial kits detected only 1/10 and 1/1000 of the
proiactin identified by immunoblot in peaks 1 and 2,
respectively.
Eur. J. Clin. Chem. Clin, Biochem. / Vol. 31,1993 / No. 12
820 L hrke et al.: Prolactin heterogeneity
Mr Mr Mr Mr Mr Mr
[103J [103] [103]




. Λ/·': ; :"
•; ;
kMV>*" ;











. · . .
































































































Eur. J. Clin. Chem. Clin. Biochem, / Vol. 31, 1993 / No. 12
L hrke et al.: Proiactin heterogeneity 821
of the flight type group the control of the fight type
group reacted to the repeated bleeding stress with an
increase in the prolactin forms. In the flight types at
the start of the experiment (frequency of the forms at
0 min) the animals intended to respond to thyroliberin
and the control revealed differences. Despite this in-
dividual variability they responded to the neurohor-
mone with an increase in the forms with Mr < 30 000
but later (at 60 min) than the fight types. These
animals with violent defence reacted already 15 min
after the thyroliberin infusion with the expression of
two additional prolactins of Mr < 30 000 (the corre-
sponding means at 0 and 15 min were 2.5 ± 0.5 versus
4 ± 1). The thyroliberin effect on the number of the
prolactin forms was dose-dependent, after dose of
4 μg/kg body weight the prolactin pattern showed
only a slight tendency to alter (data not shown),
whereas 8 μg/kg body weight caused the change de-
picted in figure 4.
The bioactivi ty of the concanavalin A-Se-
pharose bound prolactins depends on the cell
types used as targets
The dose-response to glycosylated prolactins con-
tained in peak 2 of the concanavalin A-Sepharose
affinity chromatography was compared with that of
standard prolactin of MT 20 000 (electrophorized un-
der non-reducing conditions) from the commercially
available prolactin assay kit, using murine splenocytes
activated by concanavalin A (fig. 5a) and activated
semiallogeneically (fig. 5b). Proliferation of spleen
cells was enhanced (estimated indirectly by
[3H]thymidine incorporation) in the presence of gly-
cosylated prolactins, independently of the method of
activation. The stimulatory effect was dose-depend-
ent. A low prolactin level of 2.5 μg/l increased the
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Fig. 4. Alteration in the number of circulating prolactin forms
by the hypothalamic neurohormone, thyroliberin.
To investigate the proposal that relation between hy-
pothalamic activity and prolactin response in stress is
specified by a certain physiological situation defined by
the behaviour, two breeds of cattle (Galloway and Frie-
sian) were used to model differences in the production
of prolactins. The two groups were distinguished by the
ilight-fight syndrome under stress. Two and four ani-
mals (control and treatment groups, respectively) of the
Galloway (bars 1 and 2 from a bar group) and Friesian
(bars 3 and 4 from a bar group) were used.
The Galloways, with their violent defence behaviour,
tried to overcome the venipuncture stress through butt-
ing and kicking whereas the Frisians tried to escape the
blood drawing stress through flight despite being
trapped. The treatment group received thyroliberin
(8 μg/kg) in physiological saline, the control group phys-
iological saline (2 ml). The bars indicate the number
(mean of the group) of bands (frequency) that stained
positively in the immunoblot at the start of infusion (0
minutes) and after the infusion (15 and 60 minutes) in
the range of Mr 14 500-30 000. The small bars represent
SD.
Fig. 3. Profiles of gels visualized by Coomassie dye binding (a), silver staining (b), immunoblot (c), and glycan detection blot
(d).
Electrophoresis was performed in sodium dodecyl sulphate polyacrylamide gels (12.5%). Each well was loaded with 3 μg
protein, using preparation number 1 listed in figure 1.
The Coomassie-stained lanes of panel a represent
3: transferrin (2 jig), used as a standard glycosylated protein, Mr 80000, with a glycan content of 58 g/kg protein.
2: bands of Mr 14500, 16000, 24000, 25000, 27000, 29000 and 64000,
1: molecular mass standards of Mr 94000, 67000, 43000, 30000, 20100 and 14400.
The silver-stained lanes (panel b) represent
1: molecular mass standards as described.
2: bands of Mr 14500, 16000, 24000, 25000, 27000, 29000, 60000 and 64000.
3: transferrin.
The dmmunoblot (panel c) revealed bands of Mr 16000, 25000, 27000, 29000 and 60000-64000 in lane 2. Lane 1
contains the marker proteins (rainbow standards, Pharmacia). Transferrin was loaded as a negative control in lane 3.
Polyclonal rabbit antihuman prolactin antiserum (DAKO) and antirabbit peroxidase-conjugated biotin-avidin antibody
system (Vector Laboratories) were used in the immunoblot.
The glycan detection (panel d) indicates that the Mr 60000—64000 material was heavily stained whereas the bands of
16000, 25000, 27000 and 29000 were weakly stained. Lane 3 shows the staining of transferrin used as positive control.
The glycan moiety per blotted band was determined with the glycan detection kit (Boehringer).
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Fig. 5. Opposite effects of non-glycosylated and glycosylated prolactin forms on the proliferation of concanavalin A-stimulated
(a) and semiallogeneically stimulated (b) spleen cells from mice.
Splenocytes from mice (1.5 · 10s per well of a 96-culture plate) were activated by concanavalin A (5 rug/1) or by mixing
the maternal cells (1 · 10s) with splenocytes (1 · 10s) from offspring aged 3 days (semiallogeneic stimulation). The cells
were incubated for 5 days without (control), and with prolactin standard non-glycosylated forms of Mr 20000 or 23000
from a commercially available prolactin assay kit, or with glycosylated prolactins bound to concanavalin A-Sepharose
which are defined in figure 1. The prolactin concentrations and the [3H]thymidine incorporation are given on the abscissa
and ordmate, respectively. The stimulatory activity was reversed by antiprolactin antiserum (DAKO) using 1 mg of the
purified immunoglobins per litre of the culture medium (data not shown). Addition of glycosylated prolactins compensated
partly the inhibitory activity of non-glycosylated prolactins. The compensation effect was statistically significant. The bars
represent the means, and the small bars mark the SEM. The experiments were run in duplicate with 3 repeats per variant.
with the control (stimulation without prolactin). The
stimulatory baseline (control) was higher in the semi-
allogeneic experiment, but the relative stimulation by
prolactin was smaller (fig. 5b).
To assess the specifity of the effect, purified antipro-
lactin antiserum was added and this reversed the
proliferative activity whereas the preimmune serum
was not active (data not shown). Proliferation of
splenocytes, which had been activated semiallogenei-
cally (fig. 5b) or by concanavalin A (fig. 5a), was
inhibited significantly and in a dose-dependent man-
ner by standard prolactin. Addition of glycosylated
prolactins to the culture medium decreased this inhi-
bition of proliferation by standard prolactin. The
difference (0.4 ± 0.03 pmol versus 0.5 ± 0.02 pmol
thymidine incorporation in the presence of standard
prolactin and both prolactin forms, respectively) was
statistically significant.
Bovine cells were used to study the bioactivity of the
prolactins that did not bind to concanavalin A-Se-
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pharose (unbound prolactin fraction), or were re-
tarded in their migration through a concanavalin A-
Sepharose column (retarded prolactin fraction). These
fractions were available in sufficient amounts for
dose-dependent triplicate experiments (fig. 6).
Thymidine incorporation into bovine spleen cells was
markedly increased (3.5 — 4 times the control) in the
presence of unbound prolactin fraction (2 g/l), this
stimulation decreased with increasing unbound pro-
lactin fraction concentration, but was still apparent
at 16 g/l (about twice the control). In contrast,
unbound prolactin fraction was no longer stimulatory
at ^g/l(fig.6a).
Bovine granulosa cells responded in dose-dependent
fashion to retarded prolactin fraction with a signifi-
cant increase of thymidine incorporation at low con-
centration (2 g/l) and a significant inhibition at 16
g/l, whereas the unbound prolactin fraction stimu-
lated in the concentration range 2 — 16 g/l (fig. 6b).
Thymidine incorporation into bovine oviduct epithe-
lial cells showed a constant stimulation (about 1.6
times the control) for all unbound prolactin fraction
concentrations between 2 and 16 g/l, whereas the
stimulation by retarded prolactin fraction decreased
with increasing concentration, becoming constant
(about 1.2 times the control) at 8 and 16 g/l (fig.
6c). Highly purified stromal cells from the endome-
trium responded to retarded prolactin fraction dose-
dependently, showing maximal stimulation at 4 g/l
whereas unbound prolactin fraction stimulated the
thymidine incorporation markedly (2 — 2.5 times the
control) at all concentrations examined (fig. 6d).
Discussion
Although the molecular heterogeneity of prolactin in
amniotic fluid has been described (1, 2) there appear
to be no reports on the variability between individual
fluids from full-term deliveries. In the present study
we found considerable differences in the prolactin
patterns of individual amniotic fluid samples, and
only one form of prolactin (Mr 29 000) was present
in all 6 specimens studied. Surprisingly, the prolactins
of Mr 20 000 or 23 000, defined as pure non-glycosy-
lated prolactin (1, 3) were detected only in 3 cases,
whereas the forms of Mr 14500, 24000, 27000,
39 000 -^ 41 000,60 000 - 64 000, 87 000, and 117 000 -
125 000 were more frequent. Except for the prolactins
of Mr 60000 — 64000, which were evident as a double
band in electrophoresis as well as in immunoblotting
or in the glycan detection blot, most of the other
prolactin forms were also found in human serum (1,
8) or follicular fluid (9), and in rat pituitary extracts,
rat pituitary cell aggregate cultures (5) or rat blood
plasma (10). The Mr 22000 prolactin form is defined
in rat as unglycosylated monomer (10), whereas in
the human the Mr 20 000 or 23 000 band under non-
reducing or reducing conditions is attributed to pure
prolactin (1). Thus exact comparability of prolactin
patterns is restricted to intraspecies studies. Recently
it has been reported (1) that the Mr 64000 form was
evident in human amniotic fluid only under reducing
conditions (using ß-mercaptoethanol as reducing
agent). After processing the amniotic fluid with an
organic phase and urea, this form is also detectable
under non-reducing conditions, as presented here.
Moreover, reducing conditions in the electrophoresis
did not alter this highly glycosylated prolactin form
or any other forms of Mr < 100000. However, dial-
ysis against glycine or bicarbonate buffer, pH 9.5 —
10 (with ammonia) at 6 °C for 24 hours, causes the
Mr 25000-29000 forms to disappear, whereas the
forms of Mt 20000-23000 remain (unpublished
data). The use of such pH values in the extraction of
prolactin from pituitary in standard procedures for
prolactin preparation may therefore produce arte-
facts.
In vivo, the forms of MT 20000 or 23000 (detected
under reducing conditions) are evident in serum after
administration of thyroliberin but nearly absent in
eu- and hyperprolactinaemia without thyroliberin
treatment (1). In contrast, the form of MT 14500
persists in hyperprolactinaemia and is absent in nor-
moprolactinaemia but can be induced by thyroliberin
(1). Moreover, such thyroliberin-induced circulating
prolactins appear to decay more slowly (19).
Reported investigations of hypothalamic-mediated al-
terations in circulating prolactin forms appear to be
limited to the effects of thyroliberin, with no consid-
eration of the individual behavioural response to emo-
tional stimuli. We therefore used two behaviourally
different breeds of cattle to monitor the effect of stress
on the pattern of prolactin production. The results
demonstrate striking differences in the number of
prolactin forms between the behavioural groups.
Moreover, following stress, the number of different
molecular mass forms varies with time, and the tem-
poral response of this prolactin pattern is affected
differently by thyroliberin, depending on the behav-
ioural breed.
It is not known whether stress-mediated thyroliberin
secretion alters the amniotic fluid prolactin pattern.
However, as most prolactin forms are found in both
amniotic fluid and serum, one is tempted to speculate
that the different individual prolactin patterns re-
ported here are due, at least in part, to the stress
intensity and the stress susceptibility at birth.
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The lack of a constant prolactin pattern complicates
the problem of detection. An attempt was made to
exploit the affinity of glycosylated prolactins to con-
canavalin A-Sepharose, to obtain defined forms of
the hormone. The affinity chromatography actually
separated the different forms, but with only moderate
efficiency. The failure of some glycosylated forms to
bind to concanavalin A-Sepharose has been reported
(3), using a prolactin source other than amniotic fluid.
In two of the six amniotic fluids, two well resolved
peaks were obtained in both the washing and elution
procedures. The prolactin-enriched material from the
other amniotic fluids was separated as shouldered
peaks. The second peak of the first dimer or the
shoulder of the first peak is probably due to weak
interactions between the glycan moiety of the prolac-
tins and the concanavalin A groups of the Sepharose,
since the direct glycan detection of the blotted forms
revealed that they are glycosylated. Quantitation of
the degree of glycosylation was difficult because of
technical difficulties in the use of the kit, but the
glycan moiety of the forms of MT 25000-29000
appears to be smaller than that of transferrin (58 μg
glycan groups per mg protein) while the forms of MT
60000 — 64000 are much more highly glycosylated
than transferrin.
It was recently reported that the glycosylation heter-
ogeneity of prolactin affects the diagnostic accuracy
of prolactin determinations (4). As demonstrated here,
only about 1/10 of the prolactin forms of the first
peak from the concanavalin A-Sepharose chromato-
gram were monitored by commercial prolactin kits,
although 74—83% of the proteins consisted of pro-
lactin, according to the immunoblot. The pure pro-
lactin forms from the second dimer were virtually
undetected.
This brings into question the definition of dys- or
normoprolactinaemia by commonly used immuno-
assays. However, whether accurate measurement of
the different forms of prolactin is necessary depends
on the biological significance of glycosylation. To
approach this question, glycosylated prolactins of
high purity were examined in spleen cells activated by
concanavalin A or by semiallogeneic interaction, i. e.
in a system which may be relevant to the in vivo
situation. To investigate possible channelling of cir-
culating forms to target cells by glycosylation we also
studied the bioactivity of prolactins in various model
physiological situations, using cells from the bovine
reproductive tract and spleen. Despite the considera-
ble work reported on the effects of prolactin on cells
from the reproductive tract or spleen, information on
the bioactivity of different forms of prolactin is not
available.
However, it is known that human and rat endometrial
stromal cells produce prolactin in response to proges-
tins (11). Rat placenta (20) or decidua (26) and human
myometrial explants (12) synthesize molecular forms
of Mr 23000, 27000 and 29000. Human amniotic
fluid prolactin is presumably derived from this source
(13). In an autocrine or paracrine manner, the endo-
metrial stromal cells not only produce prolactin but
also begin to proliferate and differentiate into decid-
ual cells in response to prolactin (14) during the early
stage of pregnancy. Our bovine and murine cell mod-
els showed that concanavalin Α-fractionated prolac-
tins exert dose-dependent, different or opposite effects
on bovine cells from the reproductive tract (endo-
metrial stroma, oviduct, granulosa) and on bovine or
murine splenocytes. The murine spleen cells were
semiallogeneically activated to reproduce the possible
situation in vivo during implantation and haemo-
chorial placentation, in which the semiallogeneic tro-
phoblast evades destruction by the mother's immune
system despite the intimate contact with the maternal
blood. According to the presented results, the prolif-
eration of activated splenocytes is inhibited by non-
glycosylated prolactin forms but enhanced by certain
glycosylated forms from amniotic fluid, suggesting
that the balance of these two prolactin forms is part
of an immune-endocrine mechanism in the feto-pla-
cental unit for maintaining pregnancy. Displacement
experiments (4) show that despite different affinities
the prolactin forms are bound to prolactin receptors.
Thus, different forms of circulating prolactin can
compete for a binding sites, thereby signalling an
altered physiological situation.
The existence of different forms of prolactin with
specialized roles is not without precedent. The struc-
tural form of the prolactin molecule available to the
Fig. 6. The bioactivity of prolactin forms in bovine cells:
(a) splenocytes, (b) ovarian granulosa, (c) epithelial cells from the oviduct, (d) stromal cells from the endometrium.
The bars represent the effects of the prolactins that did not bind to concanavalin A-Sepharose, corresponding to fractions
6—11 -in figure 2 (first bar from a bar group), and the effects of prolactins that were retarded on the concanavalin A-
column, corresponding to fractions 12—20 in figure 2 (second bar from a bar group). The rate of the [3H]thymidine
incorporation for each prolactin concentration (i) is given in relation to the control c (i/c). The small bars represent the
standard deviations. An asterisk marks significant difference from the control. The experiments were run in triplicate with
triplicate repeats per concentration variant.
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target tissue may be crucial for the normal function
of the tissue, as suggested by experiments on the
effects of glycosylated and non-glycosylated prolac-
tins on islet cell division and insulin secretion in ho-
mologous and heterologous systems (22, 23). More-
over, it has been reported that thymidine incorpora-
tion into gonadotrophs and thyrotrophs, but not
other pituitary cell types, is increased by prolactin of
Mr 16000, whereas the main forms were inactive (5).
Bioactivity of prolactin is modified not only by gly-
cosylation, cleavage or aggregation but also by phos-
phorylation (21). Cell division of pituitary tumour
cells was promoted only by dephosphorylated prolac-
tin (Mr 24000), whereas phosphorylated forms may
exert an inhibitory effect. In addition, the molecular
mechanisms triggered by prolactin seem to differ
among lymphoma types such as rat Nb2 and murine
L2 cells. Both are proposed as useful systems for
providing information about cellular events depend-
ent on prolactin. However, stimulation of L2 cells
caused a 7-fold increase in the prolactin receptor level
and an accumulation of prolactin receptor mRNA
(24), whereas Nb2 cells, which likewise require pro-
lactin for growth, responded to the hormone with a
rapid increase in prolactin receptor mRNA level; in
contrast to L2 cells, the level of prolactin receptor
mRNA declined time-dependently below the baseline
after stimulation, suggesting that the level is under
negative control (25). Whether these cell types re-
spond differently to different forms of circulating
prolactin is not known. Moreover, inhibition of lym-
phocyte proliferation by glucocorticoids was reversed
by prolactin in lymphocytes from normal mice, but
not in those from tumour-bearing mice (27). Reversal
of immunosuppression by prolactin and prolactin se-
cretagogues in normal mice has been confirmed by
another report (28). However, prolactin not only mod-
ifies the activity of resting and mitogen-induced nor-
mal mononuclear immunocytes (29, 30). When stim-
ulated, these cells start to synthesize and secrete pro-
lactin forms (12, 31), suggesting that prolactins are
autocrine growth factors in lymphocytes. Moreover,
stimulated mononuclear immunocytes, representing
infection stress, produce cytokines such as interleukin
1 and 2, tumour necrosis factor a, and γ-interferon,
which induce the hypothalamus to secrete corticoli-
berin and the pituitary gland to release proopio-
melanocortin, interleukin 6 and prolactin (17,18, 32).
That generally such stress-related prolactins differ
from normal circulating forms is suggested by the
present data. Our data also indicate that targeting
of the circulating prolactin signals may depend on
competition for binding sites. But our experiment^do
not exclude the existence of specific receptors for
signal transduction (33).
The dissimilarities in the properties of the individual
prolactin forms, such as receptor-binding affinity (4),
and efficacy in a given physiological situation, not
only account for the different biological activities of
prolactin, but also demonstrate the need for an ac-
curate and physiologically relevant definition and as-
say of the different forms of prolactin.
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